|Articles|December 14, 2017
TFS Partners With OmniComm to Use TrialMaster® EDC
Advertisement
TFS International has signed a new three-year partnership agreement with OmniComm Systems, Inc. in which TFS will use OmniComm’s TrialMaster EDC technology to develop clinical studies in multiple TFS research sites around the world. Clinical trial managment along with new medicines being brought to the market are a few of the benefits to this collaboration.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
3
ACT Brief: Data Pipeline Fragmentation, Vaccine Trial Pressures, and BTK Degrader Partnership
4
ACT Brief: Enterprise Risk Management, Execution Architecture for AI, and Rare Pediatric Regulatory Support
5